Hemangiopericytoma and antiangiogenic therapy: Clinical benefit of antiangiogenic therapy (sorafenib and sunitinib) in relapsed Malignant Haemangioperyctoma /Solitary Fibrous Tumour

Julien Domont, Christophe Massard, Nathalie Lassau, Jean Pierre Armand, Axel Le Cesne, Jean Charles Soria

    Research output: Contribution to journalReview articlepeer-review

    36 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)199-202
    Number of pages4
    JournalInvestigational New Drugs
    Volume28
    Issue number2
    DOIs
    Publication statusPublished - 1 Apr 2010

    Keywords

    • Antiangiogenic
    • Functional imaging
    • Sarcoma
    • Sorafenib
    • Sunitinib

    Cite this